Top Takeaways:
- Major U.S. investment – PMI U.S. commits over $800 million in manufacturing facilities, including a new Zyn plant, projected to generate hundreds of high-skilled jobs.
- Public health focus – PMI highlights its mission to help roughly 30 million adult smokers switch to FDA-authorized smoke-free products, emphasizing that it has never sold cigarettes in the U.S.
- Community & corporate responsibility – PMI U.S. has donated $25 million to charitable causes since 2022 and employs more than 2,500 people across multiple states.
Philip Morris International U.S. (PMI U.S.) on July 3 unveiled its “Invested in America” advertising campaign, outlining its commitment to American manufacturing, public health and community initiatives.
The campaign features full-page ads in national outlets like The New York Times, The Wall Street Journal, and digital platforms, promoting PMI U.S.’s role in “powering job growth, revitalizing manufacturing, improving public health…and strengthening communities.”
PMI U.S. plans to invest over $800 million in new and expanded U.S. facilities for smoke-free products. This includes its $600 million Zyn nicotine pouch plant in Aurora, Colorado—which promises 500 direct and 1,000 indirect jobs—and expanding existing production in Kentucky and North Carolina.
The campaign emphasizes the efforts as part of an “American manufacturing comeback.” CEO Stacey Kennedy underscored PMI’s long-term commitment: “Philip Morris International is invested in America’s future—and we have a proud story to tell…we will continue to create high-quality, high-paying jobs and invest in innovation for generations to come.”
PMI U.S. is positioning itself as a public-health partner, promoting FDA-authorized smoke-free alternatives to adult smokers. The company clearly states it has never sold cigarettes in the U.S. (PMI U.S. is the U.S. arm of PMI, a global tobacco company that split from Altria, the maker of Marlboro cigarettes, in 2008), focusing solely on reduced-risk, regulated nicotine products such as heat-not-burn and oral pouches.
Since 2008, PMI has invested over $14 billion globally in smoke-free product innovation. The campaign underscores this “purpose-driven performance,” noting that PMI earned over $7 billion profit on $37.9 billion net revenue in 2024.
The timing aligns with shifting regulation and consumer tastes in the U.S. PMI’s $600 million plant in Aurora is expected to open in late 2025, with production ramping up in 2026. PMI already operates manufacturing in Owensboro, Kentucky (Zyn) and Wilson, North Carolina (HEETS for IQOS).
Analysts note that PMI’s U.S. push follows its 2022 acquisition of Swedish Match—the maker of Zyn—allowing it to capture significant market share in oral nicotine pouches. Sales of Zyn soared 62% in 2023, while U.S. youth use remains low at 1.8%, according to JAMA and the National Youth Tobacco Survey.
PMI U.S.’s “Invested in America” campaign launched July 3, blending print, digital, and broadcast channels to reach policymakers, opinion leaders, and adult nicotine users, according to a press release.
